Business Context and Reporting Period
This Form 8-K is a current report filed by ReShape Lifesciences Inc. (not Vyome Holdings, Inc.) on August 16, 2021. The filing serves to announce the company's financial results for the three and six months ended June 30, 2021. The company is incorporated in Delaware and trades on the Nasdaq Capital Market under the symbol RSLS.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific numerical data for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the press release furnished as Exhibit 99.1, which is incorporated by reference but not included in the source text provided.
Material Changes
The filing text does not provide specific details regarding material changes versus prior periods. It only confirms that results for the periods ended June 30, 2021, have been issued.
Guidance, Outlook, and Risks
The text contains no management commentary, forward-looking guidance, specific risk factors, or unusual items. It explicitly states that the information furnished pursuant to Item 2.02 is "furnished" and not "filed" for purposes of Section 18 of the Exchange Act, limiting its legal liability status compared to standard filed reports.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net loss, cash position) in Exhibit 99.1 (Press Release dated August 16, 2021), as they are absent from this summary text.
- Confirm the company name is ReShape Lifesciences Inc., noting the discrepancy with the "Vyome Holdings, Inc." label in the request metadata.
- Review the full press release for any updated guidance or operational milestones not captured in this 8-K cover page.
- Check the company's status as an emerging growth company, as indicated by the unchecked box in the filing.